Results
We included 25 randomised trials which involving 2257 FLD participants. The mean sample size was 90.3 participants (ranging from 40 to 146 participants per trial). Risk of bias of the included trials was high or unclear. Twentythree different herbal medicines were tested in the RCTs. None of the trials reported death, hepatic-related morbidity, quality of life or cost. Surrogate outcomes such as serum AST, ALT, GGT, ALP, B ultrasound findings, CT scan findings and adverse effects were reported. Qinyin tea and Danning tablet did not show beneficent effects on outcomes of ALT, AST, B ultrasound and ALP. Qinyin capsule did not show beneficial significant effect on ALT (MD 17.80, 95% CI 6.35 to 29.25) . Other herbal medicines showed beneficial effect on at least one of the reported biochemical outcomes. No serious adverse events were reported.
Conclusion
Some herbal medicines may have potential effects on FLD and they appear safe to use. The findings are not confirmatory due to high or unclear risk of bias of the included trials and limited number of trials on individual herbal medicines.
